Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex

Nature Communications

Volumn 6, Issue , 2015, Pages

  Fisher, Oriana S ^a   Deng, Hanqiang ^b   Liu, Dou ^a   Zhang, Ya ^a,c   Wei, Rong ^a,b,c   Deng, Yong ^a   Zhang, Fan ^a,c   Louvi, Angeliki ^a   Turk, Benjamin E ^a   Boggon, Titus J ^a   Su, Bing ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; RHO FACTOR; RHO KINASE; ACTIN BINDING PROTEIN; MAP3K3 PROTEIN, MOUSE; OSMOSENSING SCAFFOLD FOR MEKK3 PROTEIN, MOUSE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

DISEASE PREVALENCE; EMBRYONIC DEVELOPMENT; ENDOCRINE DISRUPTOR; ENZYME ACTIVITY; NEONATE; RODENT; SIGNALING;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; CAVERNOUS HEMANGIOMA; CEREBRAL CAVERNOUS MALFORMATION 2 COMPLEX; CONTROLLED STUDY; CRYSTAL STRUCTURE; EMBRYO DEVELOPMENT; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; ANIMAL; BLOOD VESSEL; BRAIN CIRCULATION; BRAIN HEMANGIOMA; CAPILLARY PERMEABILITY; CRYSTALLIZATION; EMBRYOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEWBORN;

MUS;

ANIMALS; ANIMALS, NEWBORN; BLOOD VESSELS; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; CRYSTALLIZATION; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; INTRACRANIAL HEMORRHAGES; MAP KINASE KINASE KINASE 3; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 84938539529     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8937     Document Type: Article

References (38)

1. Labauge, P., Denier, C., Bergametti, F. & Tournier-Lasserve, E. Genetics of cavernous angiomas. Lancet. Neurol. 6, 237-244 (2007).
2. Cavalcanti, D. D. et al. Cerebral cavernous malformations: from genes to proteins to disease. J. Neurosurg. 116, 122-132 (2012).
3. Revencu, N. & Vikkula, M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 43, 716-721 (2006).
4. Yang, J. et al. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24, 309-313 (2000).
5. Uhlik, M. T. et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104-1110 (2003).
6. Hilder, T. L. et al. Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res. 6, 4343-4355 (2007).
7. Deng, Y., Yang, J., McCarty, M. & Su, B. MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis. Am. J. Physiol. Cell Physiol. 293, C1404-C1411 (2007).
8. Zhou, Z. et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. Dev. Cell 32, 168-180 (2015).
9. Boulday, G. et al. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech. 2, 168-177 (2009).
10. Whitehead, K. J. et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177-184 (2009).
11. Stockton, R. A., Shenkar, R., Awad, I. A. & Ginsberg, M. H. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 207, 881-896 (2010).
12. Fisher, O. S. et al. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations. J. Biol. Chem. 290, 2842-2853 (2015).
13. Fisher, O. S. et al. Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus. FEBS Lett. 587, 272-277 (2013).
14. Hu, Q. et al. Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure. Biochemistry 46, 13478-13489 (2007).
15. Maddaluno, L. et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496 (2013).
16. Liu, J. J. et al. A mechanism of Rap1-induced stabilization of endothelial cellcell junctions. Mol. Biol. Cell 22, 2509-2519 (2011).
17. Fischer, A., Zalvide, J., Faurobert, E., Albiges-Rizo, C. & Tournier-Lasserve, E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol. Med. 19, 302-308 (2013).
18. Borikova, A. L. et al. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J. Biol. Chem. 285, 11760-11764 (2010).
19. Richardson, B. T., Dibble, C. F., Borikova, A. L. & Johnson, G. L. Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol. Chem. 394, 35-42 (2013).
20. Wang, X., Chang, X., Facchinetti, V., Zhuang, Y. & Su, B. MEKK3 is essential for lymphopenia-induced T cell proliferation and survival. J. Immunol. 182, 3597-3608 (2009).
21. Koni, P. A. et al. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193, 741-754 (2001).
22. Zambrowicz, B. P. et al. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc. Natl Acad. Sci. USA 94, 3789-3794 (1997).
23. Hayashi, S. & McMahon, A. P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305-318 (2002).
24. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
25. Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483-486 (2010).
26. Nitta, T. et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol 161, 653-660 (2003).
27. Zhang, D. et al. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways. EMBO J. 25, 97-107 (2006).
28. Li, X. et al. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J. Biol. Chem. 285, 24099-24107 (2010).
29. Otwinowski, Z. & Minor, W. in Methods in Enzymology Vol. 276, Part A (eds Carter, C. W. & Sweet, R. M.) 307-326 (Academic Press, 1997).
30. McCoy, A. J. Solving structures of protein complexes by molecular replacement with Phaser. Acta. Crystallogr. D Biol. Crystallogr. 63, 32-41 (2007).
31. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta. Crystallogr. D Biol. Crystallogr. 66, 213-221 (2010).
32. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta. Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
33. Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta. Crystallogr. D Biol. Crystallogr. 67, 355-367 (2011).
34. Morin, A. et al. Cutting edge: Collaboration gets the most out of software. Elife 2, e01456 (2013).
35. Calabria, A. R., Weidenfeller, C., Jones, A. R., de Vries, H. E. & Shusta, E. V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 97, 922-933 (2006).
36. McNicholas, S., Potterton, E., Wilson, K. S. & Noble, M. E. Presenting your structures: The CCP4mg molecular-graphics software. Acta. Crystallogr. D Biol. Crystallogr. 67, 386-394 (2011).
37. Laskowski, R. A. PDBsum new things. Nucleic. Acids. Res. 37, D355-D359 (2009).
38. Kim, K., Duramad, O., Qin, X. F. & Su, B. MEKK3 is essential for lipopolysaccharide-induced interleukin-6 and granulocyte-macrophage colonystimulating factor production in macrophages. Immunology 120, 242-250 (2007).